Key facts
- QMB (Healthcare Services)’s last known valuation is $9.0M (Mar 2025).
- It has raised $3.1M; the latest was Seed Round ($2.0M) in Nov 2025.
- Notable investors include The Boston Foundation, C10 Labs, CEI Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for QMB (Healthcare Services)
- ·The full record, as it builds
Funding rounds
No funding rounds for QMB (Healthcare Services) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About QMB (Healthcare Services)
Provider of MedTech and biotech consulting services intended to help life science companies with the realization of effective, safe and robust life science modalities and therapies that ensure high-quality, personalized patient care. The company platform provides many services such as regulatory strategy, strategic QMS deployment, new product development, regulatory submissions, quality systems compliance, and assurance, due diligence, and more, enabling clients to get assistance with new product development, strategic quality management systems and clinical trial management.
- Sector
- Healthcare
- HQ
- Norwood, MA, United States
- Founded
- 2020
- Employees
- 18
- Website
- qmb.ai/
- Ownership
- Privately Held (backing)
QMB (Healthcare Services) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in QMB (Healthcare Services) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on QMB (Healthcare Services) in its N-PORT filings yet. We sweep new filings monthly.